id	keyword
dpc-4838	risankizumab
dpc-4838	secukinumab
dpc-4838	psoriasis
dpc-4838	patients
dpc-4838	cost
dpc-4838	efficacy
dpc-4838	study
dpc-4838	responder
dpc-4838	dermatol
dpc-4838	week
dpc-4838	treatment
dpc-4838	pasi100
dpc-4838	pasi90